Kevin Gilligan

Kevin Gilligan is a seasoned expert in the fields of virology, vaccine development, and clinical research. Since August 2018, Kevin has served as a Senior Consultant at Biologics Consulting Group, providing specialized knowledge in CMC, pre-clinical and pre-IND filing processes, with a focus on influenza and coronavirus vaccines and therapeutics. As the Founder and CEO of Gilligan Pharma Consulting LLC since May 2017, Kevin offers comprehensive consulting services in clinical study design and execution, business development strategy, and grant proposal writing. Prior roles include Sr. Director of Medical Affairs at Clinical Research Management, where Kevin led initiatives in infectious disease and clinical trial management, and Unit Chief at the US Department of Health and Human Services, overseeing antiviral drug stockpiles. Kevin's extensive experience includes significant contributions to research and development in various organizations, with a strong academic background that includes a Ph.D. in Virology from the University of North Carolina at Chapel Hill.